Table 1

Coumarin derivatives used in this study

chemical name

abbreviation

MW

Ex

Em

FI


3-(2-Benzothiazolyl-7-(diethylamino)-coumarin

BTDEC

350

474

511

34


3-(2-Benzimidazolyl)-7-(diethylamino)-coumarin

BIDEC

333

457

497

28


3-(2-Benzimidazolyl)-7-coumarin

BIC

262

456

497

24


3-(2-Benzimidazolyl)-7-(dipropylamino)-coumarin

BIDPC

361

456

497

24


3-(2-Benzoxazolyl)-7-(diethylamino)-coumarin

BODEC

369

460

502

24


3-(6-methyl-2-benzoxazolyl)-7-(diethylamino)-coumarin

MBODEC

348

458

501

10


3-(Diethylamino)-7-imino-7H-(1)benzopyrano(3',2':3,4)

pyrido(1,2-a)benzimidazole-6-carbonitrile

DIBPBC

381

554

580

32


3-(Diethylamino)-7-oxo-7H-(1)benzopyrano(3',2':3,4)

pyrido(1,2-a)benzimidazole-6-carbonitrile

DOBPBC

382

559

584

36


The fluorescence properties of coumarin derivatives were measured in DMSO. MW: molecular weight; Ex: fluorescence excitation; Em: fluorescence emission; FI: fluorescence intensity.

Watanabe et al. BMC Neuroscience 2010 11:116   doi:10.1186/1471-2202-11-116

Open Data